Search

Two second-year students -- Ellen Hukkelhoven and John Halliday -- were named Grayer Fellows for the 2010-2011 year.

… Saturday, May 1, 2010 Two second-year students were named Grayer Fellows for the 2010-2011 year. They are Ellen Hukkelhoven and John Halliday. These fellowships were established by Mr. and Mrs. Jonathan Grayer. Mr. Grayer is a member of the Gerstner Sloan Kettering Board of Trustees and the former chairman

An inherited mutation that contributes to lung cancer spread could be a target for therapies.

… Thursday, November 3, 2022 An inherited mutation in a gene called BRMS1 promotes lung cancer lung cancer metastasis.   The mutation could be targeted with therapies that prevent metastasis. Lung cancer is the leading cause of cancer death in the United States. The primary reason the disease is so deadly

Maria Jasin, PhD, a molecular biologist at the Sloan Kettering Institute, was named a recipient of the Shaw Prize in Life Science and Medicine. Dr. Jasin was recognized for her contributions to research showing that localized double-strand breaks in DNA stimulate recombination in mammalian cells.

… Tuesday, May 21, 2019 Maria Jasin, PhD , a molecular biologist at the Sloan Kettering Institute , was named a recipient of the Shaw Prize in Life Science and Medicine . Dr. Jasin was recognized for her contributions to research showing that localized double-strand breaks in DNA stimulate recombination

MSK physicians and scientists highlighted some of the institution’s latest advances in transplantation and cellular therapies at the Tandem Meetings held February 4 to 6, 2026, in Salt Lake City.

… Monday, April 6, 2026 Memorial Sloan Kettering Cancer Center (MSK) physicians and scientists highlighted some of the institution’s latest advances in transplantation and cellular therapies at the  Tandem Meetings held February 4 to 6, 2026, in Salt Lake City. The meetings, jointly hosted by the American

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Tuesday, August 17, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig Thompson Recognized in City & State’s Life Sciences Power 50 Craig B. Thompson Craig Thompson, MD , President and CEO, was named on the inaugural City & State Life Sciences Power

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.

… Friday, August 29, 2025 This past year, seven PhD students enrolled in the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) were awarded competitive fellowships from prestigious external agencies such as the National Institutes of Health (NIH) and the National Science Foundation

Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.

… Thursday, January 12, 2023 Memorial Sloan Kettering Cancer Center (MSK) and MediSys Health Network (Jamaica Hospital Medical Center and Flushing Hospital Medical Center) today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.

… Wednesday, May 18, 2022 New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach on 114 pediatric, adolescent, and young adult patients with solid tumors. The

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.

… Friday, September 28, 2018 Summary Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA for the treatment of patients with high-risk neuroblastoma. Neuroblastoma is a rare cancer of the nerve tissue that usually arises in the abdomen. It mainly affects young children

Scientists in all stages of their careers gathered recently to hear from Sharon Milgram speak about how attitudes and behaviors that can get in the way of a successful career.

… Tuesday, April 9, 2019 Summary At a recent event, GSK students and scientists from across MSK heard from Sharon Milgram about the importance of perseverance and positivity in a career in science. The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) offers a range of resources to